New pill aims to shrink hard-to-treat lung tumors
Disease control
Terminated
This study tests a new pill, poziotinib, against standard chemotherapy (docetaxel) in people with advanced lung cancer that has a specific genetic change (HER2 mutation). The goal is to see if poziotinib can keep tumors from growing longer than chemo. About 268 adults who have al…
Phase: PHASE3 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated May 14, 2026 12:06 UTC